Scarica l'app Stockscreener
547.43
2.61%
-14.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance
Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha
Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
IDEXX Laboratories (IDXX) Institutional Ownership 2026 - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDXX|IDEXX Laboratories Inc|Price:569.852|Chg%:-0.728 - TradingKey
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com
IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Eagle-Tribune
Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating - marketscreener.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc Stock Historical Valuations | HAM:IX1 - GuruFocus
IDEXX Laboratories Inc Stock Baskets - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data - GuruFocus
IDEXX Laboratories (HAM:IX1) Other Operating Expense : €0 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories (HAM:IX1) Marketable Securities : €0 Mil (As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Competitors 2026 - GuruFocus
IDEXX Laboratories Inc Stock Operating Data - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock News, Headlines & Updates - GuruFocus
Who's Buying or Selling IDEXX Laboratories Inc (HAM:IX1) Stock Today? - GuruFocus
IDEXX Labs posts 9% organic growth, raises EPS forecast, driven by global diagnostic expansion. - Pluang
IDEXX Laboratories: Worth The Premium (NASDAQ:IDXX) - Seeking Alpha
IDEXX Laboratories, Inc. $IDXX Shares Sold by Beacon Investment Advisory Services Inc. - MarketBeat
Assenagon Asset Management S.A. Boosts Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Moomoo
Janus Henderson Group PLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Clinical Visits Keep Falling. IDEXX Laboratories’ Q2 Earnings Report Say That Doesn’t Matter. - TIKR.com
IDEXX Laboratories, Inc. $IDXX Shares Sold by Empowered Funds LLC - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
IDEXX Labs Is Maintained at Neutral by UBS - Moomoo
IDEXX Labs Is Maintained at Neutral by Citigroup - Moomoo
Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792 - Moomoo
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo
Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo
IDEXX Laboratories Inc (HAM:IX1) Stock Earnings Transcripts - GuruFocus
IDEXX Laboratories Inc (IDXX) Stock Up 3.6% and Still Undervalued -- GF Score: 96/100 - GuruFocus
IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights - GuruFocus
IDEXX Laboratories 2026: Revenue $1.22B, EPS $4.27— 10-Q Summary - TradingView
IDEXX Laboratories (NASDAQ: IDXX) lifts Q2 2026 profit and cash flow - Stock Titan
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Raised to $719, Implies 27% Upside - TradingView
Idexx Laboratories, Inc. Updates Earnings Guidance for 2026 - marketscreener.com
IDEXX Laboratories jumps 5% on strong results, raised guidance (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories Q2 Earnings Call Highlights - MarketBeat
Why Is IDEXX Laboratories Stock Gaining Tuesday? - Benzinga
3.81%
1.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):